PMC:7335494 / 27873-28095 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T18","span":{"begin":53,"end":60},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"}],"text":"Observational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fatty acid formula or (3) control formula High fibre group: ↓ NF-κB in PBMCs Kim et al. (2013)"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T216","span":{"begin":53,"end":60},"obj":"Body_part"},{"id":"T217","span":{"begin":128,"end":138},"obj":"Body_part"}],"attributes":[{"id":"A216","pred":"fma_id","subj":"T216","obj":"http://purl.org/sig/ont/fma/fma82743"},{"id":"A217","pred":"fma_id","subj":"T217","obj":"http://purl.org/sig/ont/fma/fma82738"}],"text":"Observational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fatty acid formula or (3) control formula High fibre group: ↓ NF-κB in PBMCs Kim et al. (2013)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T279","span":{"begin":194,"end":195},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"Observational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fatty acid formula or (3) control formula High fibre group: ↓ NF-κB in PBMCs Kim et al. (2013)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T310","span":{"begin":53,"end":60},"obj":"Chemical"},{"id":"T312","span":{"begin":112,"end":138},"obj":"Chemical"},{"id":"T313","span":{"begin":128,"end":138},"obj":"Chemical"},{"id":"T314","span":{"begin":134,"end":138},"obj":"Chemical"},{"id":"T315","span":{"begin":181,"end":186},"obj":"Chemical"},{"id":"T316","span":{"begin":190,"end":192},"obj":"Chemical"}],"attributes":[{"id":"A310","pred":"chebi_id","subj":"T310","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A311","pred":"chebi_id","subj":"T310","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A312","pred":"chebi_id","subj":"T312","obj":"http://purl.obolibrary.org/obo/CHEBI_25413"},{"id":"A313","pred":"chebi_id","subj":"T313","obj":"http://purl.obolibrary.org/obo/CHEBI_35366"},{"id":"A314","pred":"chebi_id","subj":"T314","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A315","pred":"chebi_id","subj":"T315","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A316","pred":"chebi_id","subj":"T316","obj":"http://purl.obolibrary.org/obo/CHEBI_141424"},{"id":"A317","pred":"chebi_id","subj":"T316","obj":"http://purl.obolibrary.org/obo/CHEBI_25573"},{"id":"A318","pred":"chebi_id","subj":"T316","obj":"http://purl.obolibrary.org/obo/CHEBI_1224"}],"text":"Observational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fatty acid formula or (3) control formula High fibre group: ↓ NF-κB in PBMCs Kim et al. (2013)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T129","span":{"begin":0,"end":222},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Observational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fatty acid formula or (3) control formula High fibre group: ↓ NF-κB in PBMCs Kim et al. (2013)"}

{"project":"MyTest","denotations":[{"id":"32640331-24283276-30720814","span":{"begin":217,"end":221},"obj":"24283276"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Observational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fatty acid formula or (3) control formula High fibre group: ↓ NF-κB in PBMCs Kim et al. (2013)"}

{"project":"2_test","denotations":[{"id":"32640331-24283276-30720814","span":{"begin":217,"end":221},"obj":"24283276"}],"text":"Observational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fatty acid formula or (3) control formula High fibre group: ↓ NF-κB in PBMCs Kim et al. (2013)"}